October 2013 Issue of MMM
October 2013 Issue
MM&M's Career & Salary Survey usually throws up at least one interesting storyline or trend each year, based on an analysis of the numbers. In ...
Click the above link to access the complete Digital Edition of the October 2013 issue, with all text, charts and pictures.
Although job-cut announcements have become a part of daily life in the industry, average salaries have risen to an all-time high. Not only that, job ...
Getting two unique agency cultures to click is no simple task. Larry Dobrow examines four healthcare-agency unions and finds that marital bliss is possible
Sometimes it's a lateral move. Other times, advancing takes fancy footwork. The main thing, say these six biopharma execs, is to think on your feet. ...
Co-pay initiatives rank among the most hotly debated topics in healthcare marketing today. Pharmas and healthcare providers love them. Payers and PBMs... not so much. ...
Dagmar Rosa-Bjorkeson, VP/head, US general medicines MS business unit, Novartis
While public health agencies see eye-to-eye with industry on the need to inoculate, vaccination rates among some patient groups remain stubbornly low. Noah Pines on ...
The next generation of drugs sees a number of market access challenges
Sorting out the good and bad about e-cigarettes
According to a Stericycle ExpertRecall report, drug and pharmaceutical recalls reported by FDA in the second quarter of this year surged 127% over the previous ...
Valeant sales reps started doing something different in August. In addition to talking to dermatologists about prescription medications, they started dropping off samples of the ...
Bob Harrell, IMS Health-Appature's director of marketing says its cloud-based system Journeys, which launched in August, shows how customers are behaving in real time
News on Mission Pharmacal, Lundbeck and Boehringer Ingelheim
Med Ed Report
Providers of CME are getting better at complying with accreditation criteria, several years' worth of data show, yet tougher criteria may be in store.
In addition to donning scrubs before entering the OR, several surgeons have slipped on Google Glass, the augmented-reality enabling goggles.
News on Elsevier, CDC, Southern Medical Association and Astellas
A research team found that Big Pharma has pulled back on publications despite doubling or even quadrupling research and development budgets
American Medical News's 55-year publishing history ended September 2, although the website will be maintained through the end of the year.
Healthcare reform opens the door for innovative communications among patients, payers and physicians. But how can disparate data sets and stakeholders from across a conservative, ...
Cigna is promoting the video game Re-Mission 2, the latest version of a simulation that puts young cancer patients at the center of their own ...
Remedy Health is hoping a new-look website can help it further turn the tide in the portal wars.
News on WebMD, Doximity, WellDoc and the COPD Foundation
Shire recently launched website HealTogether.com for people and communities afflicted with diabetes and diabetic foot ulcers (DFUs).
Chantix, Pfizer's smoking-cessation drug, is back on the air with a terrific new set of testimonials.
Results from a study published in the Journal of Clinical Oncology suggest that blogging may help women with breast cancer battle depression.
Eli Lilly is tapping Humana's claims database for therapeutic study
The American College of Cardiology (ACC) said it's entered an agreement to cull insights from a healthcare database
Carolyn Morgan who has led LehmanMillet's West Coast office, was promoted to president and Deborah Lotterman to chief creative officer
Mc|K Healthcare said it resigned its largest account, UCB's Neupro patch, as the agency shifts its creative vision
News on Intouch Solutions, Cambridge BioMarketing, MedEvoke and Eveo
By opposing making clinical trial data public, Pharma is once again swimming against the current
FDA stakeholders in industry and academia told the agency in August that they're concerned about its newest initiative to make clinical trial data more publicly ...
A study of government drug review advisory panels suggests that those with members who have financial ties to the drug industry recommended expansion of labeled ...
Unfortunately, it's likely that Costco Wholesale ranks as the biggest tobacco trafficker in the US
To better serve their customers, all customer-facing team members must speak the same language
Displaying an in-your-face, post-digital sensibility, these global campaigns tell provocative stories to instigate behavioral change
Christine Armstrong, Managing director, brand experience, Giant Creative/Strategy
At Work With
Charlene Prounis, CEO and managing partner, Flashpoint Medica
Manufacturer, regulatory and agency promotions and hires
Digital DNA is an inevitability, as we cannot forever resist this societal tide
What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.
A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.